Your browser doesn't support javascript.
loading
The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma.
Ponnusamy, Kanagaraju; Tzioni, Maria Myrsini; Begum, Murshida; Robinson, Mark E; Caputo, Valentina S; Katsarou, Alexia; Trasanidis, Nikolaos; Xiao, Xiaolin; Kostopoulos, Ioannis V; Iskander, Deena; Roberts, Irene; Trivedi, Pritesh; Auner, Holger W; Naresh, Kikkeri; Chaidos, Aristeidis; Karadimitris, Anastasios.
Afiliação
  • Ponnusamy K; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London.
  • Tzioni MM; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London.
  • Begum M; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London.
  • Robinson ME; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London.
  • Caputo VS; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London.
  • Katsarou A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust, London.
  • Trasanidis N; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London.
  • Xiao X; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London.
  • Kostopoulos IV; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Section of Animal and Human Physiology, National and Kapodestrian University of Athens, Department of Biology, School of Scienc
  • Iskander D; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust, London.
  • Roberts I; Department of Paediatrics and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford.
  • Trivedi P; Department of Cellular and Molecular Pathology, Northwest London Pathology, Imperial College Healthcare NHS Trust, London.
  • Auner HW; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust, London.
  • Naresh K; Department of Cellular and Molecular Pathology, Northwest London Pathology, Imperial College Healthcare NHS Trust, London.
  • Chaidos A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust, London.
  • Karadimitris A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust, London. a.karadimitris@imper
Haematologica ; 107(3): 721-732, 2022 03 01.
Article em En | MEDLINE | ID: mdl-33596642

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article País de publicação: Itália